JP Stock MarketDetailed Quotes
4886 ASKA Pharmaceutical Holdings
- 2218
- -37-1.64%
20min DelayNot Open Sep 30 15:00 JST
67.79BMarket Cap8.32P/E (Static)
2242High2205Low76.80KVolume2205Open2255Pre Close170.88MTurnover272052wk High0.39%Turnover Ratio30.56MShares164552wk Low260.95EPS TTM43.51BFloat Cap2720Historical High8.32P/E (Static)19.62MShs Float919Historical Low266.51EPS LYR1.64%Amplitude40.00Dividend TTM1.01P/B100Lot Size1.80%Div YieldTTM
ASKA Pharmaceutical Holdings Key Stats
EPS
According to the latest financial report of ASKA Pharmaceutical Holdings, the latest earnings per share (TTM) for the company is 44.95. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about ASKA Pharmaceutical Holdings's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ASKA Pharmaceutical Holdings shows that the company's current ratio is 2.34, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ASKA Pharmaceutical Holdings, the quick ratio is 1.37, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of ASKA Pharmaceutical Holdings? The latest ROE figure is 1.78%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ASKA Pharmaceutical Holdings, the total asset return on investment (ROA) is 1.17%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ASKA Pharmaceutical Holdings's latest financial report to see how their gross margin is doing - currently at 49.97%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ASKA Pharmaceutical Holdings, the net profit margin is 7.78%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data